We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
7 result(s) found, displaying 1 to 7
-
Prescription medicine registrationActive ingredients: Glu-urea-Lys(ahx)-hbed-CC.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ILLUCCIX Configuration A Kit for the Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC 25 mcg solution for injection Glass Vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ILLUCCIX Configuration B Kit for the Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC 25 mcg solution for injection Glass Vial.
-
Australian public assessment report (AusPar)Illuccix (Glu-urea-Lys(ahx)-hbed-CC) for diagnosis of prostate cancer.
-
Prescription medicine decision summaryTGA decision: Illuccix (Glu-urea-Lys(ahx)-hbed-CC) is a radioactive diagnostic agent used to assist in the treatment of prostate cancer.
-
Prescription medicine registrationActive ingredients: Glu-urea-Lys(ahx)-hbed-CC.
-
Designation or determinationPriority review